Reduction of serum cholesterol in Watanabe rabbits by xenogeneic hepatocellular transplantation

Nature Medicine

Volumn 3, Issue 1, 1997, Pages 48-53

  Gunsalus, J Ryan ^a   Brady, Deborah A ^a   Coulter, Sarah M ^a   Gray, Brian M ^a   Edge, Albert S B ^a  

^a GENVEC INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL TRANSPLANTATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; RABBIT; SUBCUTANEOUS DRUG ADMINISTRATION; SWINE;

ANIMALS; CELL TRANSPLANTATION; CHOLESTEROL; DISEASE MODELS, ANIMAL; HYPERCHOLESTEROLEMIA; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIPOPROTEINS, LDL; LIVER; MALE; RABBITS; SWINE; TIME FACTORS; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HETEROLOGOUS;

EID: 0031022048     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0197-48     Document Type: Article

References (13)

1. Brown, M.S. & Goldstein, J.L. A receptor mediated pathway for cholesterol homeostasis. Science 232, 34-47 (1986).
2. Havel, R.J., Yamada, N. & Shames, D.M. Watanabe heritable hyperlipidemic rabbit: Animal model for familial hypercholesterolemia. Arteriosclerosis 9 (Suppl.), 1-33-1-38 (1989).
3. Yamamoto, T., Bishop, R.W, Brown, M.S., Goldstein, J.L. & Russell, D.W. Deletion in cysteine-rich region of LDL receptor impedes transport to cell surface in WHHL rabbit. Science 232, 1230-1237 (1986).
4. Buja, L.M., Clubb, F.J., Jr, Bilheimer, D.W. & Willerson, J.T. Pathobiology of human familial hypercholesterolemia and a related animal model, the Watanabe heritable hyperlipidaemic rabbit. Eur. Heart J. 11, 41-52 (1990).
5. Spady, D.K., Huehinger, M., Bilheimer, D.W. & Dietschy, J. M. Role of receptor-independent low density lipoprotein transport in the maintenance of tissue cholesterol balance in the normal and WHHL rabbit. J. Lipid Res. 28, 32-41 (1987).
6. Tejera, M.L. et al. Reduction of cholesterol levels following liver cell grafting in hyperlipidemic (WHHL) rabbits. Transplant Proc. 24, 160-161 (1992).
7. Wang, J., Pollak, R. & Bartholomew, A. Sustained reduction of serum cholesterol levels following allo-transplantation of parenchymal hepatocytes in Watanabe rabbits. Transplant. Proc. 23, 894-895 (1991).
8. Wiederkehr, J.C., Kondos, G.T. & Pollak, R. Hepatocyte transplantation for the low density lipoprotein receptor-deficient state: A study in the Watanabe rabbit. Transplantation 50, 466-476 (1990).
9. Chowdhury, J.R. et al. Long-term improvement of hypercholesterolemia after ex vivo therapy in LDLR-deficient rabbits. Science 254, 1802-1805 (1991).
10. Wilson, J.M. et al. Temporary amelioration of hyperlipidemia in low density lipoprotein receptor deficient rabbits transplanted with genetically modified hepatocytes. Proc. Natl. Acad. Sci. USA 87, 8437-8441 (1990).
11. Kozarsky, K.F. et al. In vivo correction of low density lipoprotein deficiency in the Watanabe heritable hyperlipidemic rabbit with recombinant viruses. J. Biol. Chem. 269, 13695-13702 (1994).
12. Li, J. et al. In vivo gene therapy for hyperlipidemia: Phenotypic correction in Watanabe rabbits by hepatic delivery of the rabbit LDL receptor gene. J. Clin. Invest. 95, 768-773 (1995).
13. Wilson, J.M. et al. Hepatocyte-directed gene transfer in vivo leads to transient improvement of hypercholesterolemia in low density receptor-deficient rabbits. J. Biol. Chem. 267, 963-967 (1992).